Mesoblast | MSB - Beneficio Bruto En Ventas

Precio De Mercado
2.06
Cambio Diario
0.01 0.49%
Mensual
-12.34%
Anual
-7.62%
Q1 Expectativa
2.02




Beneficio Bruto En Ventas Cambio Fecha
Avita Medical AUD 14.31M 639K 2025-12
Clinuvel Pharmaceuticals AUD 57.82M 18.86M 2024-06
Cochlear AUD 856.8M 430M 2025-12
CSL USD 4.46B 2.71B 2025-12
Pacific Edge NZD 5.2M 1.75M 2024-06
Paradigm Biopharmaceuticals AUD -9K 423.94K 2025-06
PYC Therapeutics AUD 5.83M 750K 2025-06
Ramsay Health Care AUD 549.95M 5.77B 2025-06
Sonic Healthcare AUD 3.92B 3.14B 2024-12
Starpharma Holdings AUD -736K 2.82M 2025-06
Telix Pharmaceuticals AUD 217.82M 9.23M 2025-12